Company news
Caris Life Sciences, Inc. news in 2025
Caris Life Sciences, Inc.'s news releases, calls and decks from 2025, newest first.
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
December 18, 2025
Caris Life Sciences Announces Collaboration with Genentech to Discover Novel Therapeutic Targets in Cancers with High Unmet Clinical Need
December 15, 2025
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
December 3, 2025
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute
December 1, 2025
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
November 20, 2025
Caris Life Sciences to Attend Q4 2025 Investor Conferences
November 16, 2025
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
November 4, 2025
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response
October 28, 2025
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025
October 22, 2025
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025
October 13, 2025
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®
August 14, 2025
New Study from Caris Life Sciences Validates Optimal Sequencing in Informing Therapy Choices for Breast Cancer Subgroups
August 13, 2025
Caris Life Sciences Reports Second Quarter 2025 Financial Results
August 12, 2025
Caris Life Sciences Publishes Study Showing AI Signature-positive Breast Cancer Patients Live Almost Twice as Long as AI-negative Patients When Treated with a Checkpoint Inhibitor
August 6, 2025
Caris Life Sciences Publishes Study Showing its Multi-Layer AI-Based Tissue of Origin Predictions are Best-in-Class and Identify when Patients have been Misdiagnosed
August 5, 2025
Caris Life Sciences to Report Second Quarter 2025 Financial Results on August 12, 2025
July 23, 2025
Caris Life Sciences Validates and Extends Findings on Tumor-Infiltrating Clonal Hematopoiesis
July 22, 2025
Caris Life Sciences Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure® Blood-Based Assay for Multi-Cancer Early Detection, Minimal Residual Disease and Therapy Selection
July 8, 2025
Calls in 2025
Decks in 2025
- Q3 2025 Earnings Presentation
Earnings · 17 slides · Nov 5, 2025
- Q2 2025 Earnings Presentation
Earnings · 17 slides · Aug 12, 2025